Key facts
- Notable investors include Lingyi Capital, Fan Zhuo Capital, Galileo Venture.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bejerui
- ·The full record, as it builds
Funding rounds
No funding rounds for Bejerui are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bejerui
Manufacturer of biomedical imaging instruments designed to enable non-invasive analysis and monitoring of living cells and blood samples. The company offers label-free quantitative phase imaging microscopes with integrated artificial intelligence analysis, automated imaging, and environmental control, enabling life science researchers and healthcare professionals to obtain accurate cellular insights and support early disease detection.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2019
- Website
- bayjayray.cn/
- Ownership
- Privately Held (backing)
Bejerui doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bejerui shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bejerui in its N-PORT filings yet. We sweep new filings monthly.